Interruptions in therapy, whether due to financial constraints, insurance issues, or drug shortages, can complicate treatment and increase the risk of GI AEs when therapy is resumed at the previous dose
NPs running independent weight loss programs typically earn $150K$250K+ annually from GLP-1 program fees, lipotropic injections, and ancillary services
Introduction Imagine a superhero in your body, tirelessly working to combat oxidative stress, boost your immune defenses, and support cellular repair
In a landmark human trial comparing topical GHK-Cu to vitamin C and retinoic acid (tretinoin), GHK-Cu produced measurable collagen increases in 70% of study volunteers outperforming both comparator treatments (Abdulghani et al., 1998)
The discovery and development of liraglutide and GLP-1